HER2-positive breast cancer: a new piece of the puzzle

Lancet Oncol. 2014 Jun;15(7):668-9. doi: 10.1016/S1470-2045(14)70192-5. Epub 2014 May 2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Ado-Trastuzumab Emtansine
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Maytansine / analogs & derivatives*
  • Maytansine / therapeutic use
  • Receptor, ErbB-2 / analysis*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Maytansine
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab
  • Ado-Trastuzumab Emtansine